Why is "Primary biliary cholangitis" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-05-17 23:09:52
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Primary_biliary_cholangitis entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-05-17 and was most recently seen on 2026-05-17.
Wikipedia Overview
Primary biliary cholangitis (PBC), previously known as primary biliary cirrhosis, is an autoimmune disease of the liver. It results from a slow, progressive destruction of the small bile ducts of the liver, causing bile and other toxins to build up in the liver, a condition called cholestasis. Further slow damage to the liver tissue can lead to scarring, fibrosis, and eventually cirrhosis.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Primary Biliary Cholangitis: A New Treatment Paradigm - Gastroenterology & Endoscopy News
-
Patients Suffering from Primary Biliary Cholangitis (PBC) Push Back on Stigma - Yahoo Finance
-
What To Eat To Help Manage Primary Biliary Cholangitis - health.clevelandclinic.org
-
Resistant primary biliary cholangitis: treatment with Elafibranor - Clínica FEHV
-
Treatment Sequencing in Primary Biliary Cholangitis - Medscape Reference: Drugs, Diseases & Medical Procedures
-
Seladelpar (Livdelzi) raises the bar for primary biliary cholangitis treatment - 2minutemedicine.com
-
The impact of male sex on outcomes in primary biliary cholangitis - Nature
-
Primary Biliary Cholangitis in the Middle East: A Review of Current Challenges and Treatment Approaches - Cureus
-
Baseline Alkaline Phosphatase Impacts Response Rates in Primary Biliary Cholangitis: Exploring Response to Elafibranor in ELATIVE - onlinelibrary.wiley.com
-
Liver–kidney crosstalk in primary biliary cholangitis: insights into the mechanisms of renal involvement - Frontiers
-
Improving Disease Management in Primary Biliary Cholangitis - EMJ
-
Treating primary biliary cholangitis - Mayo Clinic Press
-
FDA approves first drug for itch due to primary biliary cholangitis - FirstWord Pharma
-
FDA Approves Linerixibat for Cholestatic Pruritus in Primary Biliary Cholangitis - The American Journal of Managed Care
-
Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to Treat Primary Biliary Cholangitis (PBC) Granted Priority Review by the US FDA - PR Newswire
-
Nearly 1 in 10 Patients With Primary Biliary Cholangitis Have Chronic Kidney Disease - Medscape
-
Diagnostic potential of salivary biomarkers for primary biliary cholangitis: a systematic review - Frontiers
-
IGFBP4 is a Metric for Primary Biliary Cholangitis and Attenuates Biliary Epithelial Cell Injury - onlinelibrary.wiley.com
-
Altered sphingolipid profile in primary biliary cholangitis: associations with fibrosis and inflammation - Nature
-
Vitamin D3 attenuates hepatic inflammation in primary biliary cholangitis by inhibiting TLR4/NF-κB mediated M1 macrophage polarization | Scientific Reports - Nature
-
Protect Your Well-Being With Primary Biliary Cholangitis - Everyday Health
-
Can Hypnosis Help Women With Primary Biliary Cholangitis and Fatigue? Read the Study in the May Issue of The American Journal of Gastroenterology | Newswise - Newswise
-
Fenofibrate-UDCA Combination Therapy Safe and Effective for Primary Biliary Cholangitis - Cleveland Clinic
-
Addressing the Symptom Burden of Primary Biliary Cholangitis - Medscape Reference: Drugs, Diseases & Medical Procedures
-
Molecular mechanisms underlying T cell subset imbalance and precision therapeutic targets in primary biliary cholangitis - Frontiers
-
NICE approves seladelpar for primary biliary cholangitis - The Pharmaceutical Journal
-
FDA Grants Priority Review to Saroglitazar NDA for Primary Biliary Cholangitis - HCPLive
-
Impact of Alkaline Phosphatase Normalization on... : American Journal of Gastroenterology - Lippincott Home
-
Saroglitazar Boosts Response Rates in Primary Biliary Cholangitis - MedPage Today
-
Selective PPARα Modulator "K-808" (Pemafibrate) Granted "Breakthrough Therapy" Designation by the U.S. Food and Drug Administration (FDA) As a Treatment for Primary Biliary Cholangitis - PR Newswire
-
FDA Approves Linerixibat for Cholestatic Pruritus in Primary Biliary Cholangitis - Pharmacy Times
-
Exploring primary biliary cholangitis - Healio
-
Statin Use Linked to Lower Hepatic Decompensation Risk in Primary Biliary Cholangitis - Medscape
-
PBC patients see disease markers rebound after trial as Korea reimbursement lags - Korea Biomedical Review
-
Transjugular intrahepatic portosystemic shunt for hepatic sinusoidal obstruction syndrome with primary biliary cholangitis and alcoholic liver disease: a case report - Frontiers
-
Volixibat Improves Fatigue and Sleep in Patients With Primary Biliary Cholangitis - HCPLive
-
Primary biliary cholangitis–associated osteoporosis: contemporary review of pathogenesis and management - EurekAlert!
-
Bezafibrate for primary biliary cholangitis: time to act on the evidence - Nature
-
COUR Pharma reports one-year Phase IIa data for PLGA nanoparticle drug in primary biliary cholangitis - allsci.com
-
Trends in Primary Biliary Cholangitis: Prospective Cohort Study From the European Reference Network Registry (R-LIVER) - onlinelibrary.wiley.com
-
FDA approves GSK's Lynavoy for cholestatic pruritus in primary biliary cholangitis - allsci.com
-
Long-Term Use of Fenofibrate as Second-Line Therapy in Primary Biliary Cholangitis: A Retrospective Study - onlinelibrary.wiley.com
-
Seladelpar Improved Itch, Itch-Related Sleep Disturbance and Measures of Fatigue in Patients With Primary Biliary Cholangitis and Pruritus in the Phase 3 RESPONSE Trial - onlinelibrary.wiley.com
-
Primary Biliary Cholangitis Pipeline Shows Potential with Active Contributions from 20+ Key Companies | DelveInsight - Barchart.com
-
Blood group A linked to a higher risk of primary biliary cholangitis - News-Medical
-
FDA Approves Lynavoy for PBC-Associated Pruritus - Gastroenterology & Endoscopy News
-
COUR Pharma Announces Positive One-Year Results from the - GlobeNewswire
-
Alfasigma bets up to $690M on GSK’s late-stage PBC itch drug ahead of FDA decision - european-biotechnology.com
-
New approaches to treating a rare disease affecting the liver - UB - Universitat de Barcelona
-
Osteoporosis in primary biliary cholangitis: from cholestasis to fracture prevention - Termedia
-
Lynavoy recommended for EU approval by the CHMP - PharmaTimes
-
Alfasigma Pays $300M for Rights to GSK Rare Liver Disease Drug On Track for FDA Decision - MedCity News
-
New PBC therapy found to reduce liver scarring after 1 year in US trial - Liver Disease News
-
Gilead touts Phase III win that could put Livdelzi on track for wider PBC label - FirstWord Pharma
-
Key Symptoms of PBC- Fatigue, Pruritus, and Bone Health - HCPLive
-
Beyond Ursodeoxycholic Acid: A Comprehensive Review of Second-Line Agents in Primary Biliary Cholangitis - Cureus
-
Linerixibat secures CHMP backing as first targeted therapy for cholestatic pruritus in primary biliary cholangitis. - allsci.com
-
Seladelpar Staves Off Liver Stiffness in Primary Biliary Cholangitis - Medscape
-
FDA approves treatment for debilitating itch in rare liver disease - Managed Healthcare Executive
-
Gilead to Present New Data Advancing Care in PBC and Viral Hepatitis at EASL 2026 - Business Wire
-
Your Good Health: Know the difference between certain types of cholangitis - Times Colonist
-
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis - NEJM
-
Most recent liver stiffness test best predicts risk of PBC progression - Liver Disease News
-
Primary Biliary Cholangitis - liverfoundation.org
-
From dive trips to a transplant: One woman’s battle with a rare autoimmune liver disease - CNA Lifestyle
-
Clinical trial results suggest potential new treatment for primary biliary cholangitis - health.ucdavis.edu
-
A Rare Case of Concurrent Primary Biliary Cholangitis and Sarcoidosis - Cureus
-
FDA Approves First Drug for Cholestatic Pruritus in Primary Biliary Cholangitis - Medical Dialogues
-
Liver Disease Medication Linked to Lower Cancer Risks - MedPage Today
-
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis - NEJM
-
Dissecting causal relationships between primary biliary cholangitis and extrahepatic autoimmune diseases based on Mendelian randomization - Nature
-
Long-term outcomes in patients with primary biliary cholangitis complicated with CREST syndrome - Nature
-
Marine perseveres through health problems after service - The War Horse
-
Bidirectional Mendelian randomization links gut microbiota to primary biliary cholangitis - Nature
-
NEW DRUG: Lyvdelzi for primary biliary cholangitis - Canadian Healthcare Network
-
UDCA Use in Primary Biliary Cholangitis Associated With Reduced Cancer Risk: JAMA - Medical Dialogues
-
Unique DUOX2+ACE2+ small cholangiocytes are pathogenic targets for primary biliary cholangitis - Nature
-
Long-Term Elafibranor Treatment Leads to Biochemical, Symptomatic Improvements in PBC - HCPLive
-
Latest Livdelzi Safety, Efficacy Data Presented at The Liver Meeting 2025 - Managed Healthcare Executive
-
Novel Therapies for Adults With Primary Biliary Cholangitis - Medscape Reference: Drugs, Diseases & Medical Procedures
-
PBC worst for life quality among autoimmune liver diseases: Study - Liver Disease News
-
Exploring life and parenthood with Primary Biliary Cholangitis - Ipsen
-
LYVDELZI® (SELADELPAR) RECEIVES HEALTH CANADA APPROVAL FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS - PR Newswire Canada
-
Primary biliary cholangitis: pathogenesis and therapeutic opportunities - Nature
-
Research progress and perspectives of non-coding RNAs in primary biliary cholangitis: from mechanisms to therapeutics - Frontiers
-
Primary biliary cholangitis: Your guide to diet and nutrition - Mayo Clinic Press
-
Common pathological mechanisms and therapeutic strategies in primary Sjogren’s syndrome and primary biliary cholangitis: from tissue immune microenvironment to targeted therapy - Frontiers
-
Liverace Explains Primary Biliary Cholangitis (PBC) - liverfoundation.org
-
Primary biliary cholangitis: diagnosis and management - The Pharmaceutical Journal
-
Systemic Sclerosis and Primary Biliary Cholangitis: A Comprehensive Review of Two Overlapping Rare Entities With Insights on Diagnostics and Management - Cureus
-
Quality Measures to Enhance the Management and Treatment of Primary Biliary Cholangitis: A Delphi Consensus Study - onlinelibrary.wiley.com
-
Women with PBC may be at high risk of disease flares after childbirth - Liver Disease News
-
Development and external validation of an early prediction model to identify irresponsive patients and prognosis of UDCA treatment in primary biliary cholangitis - Nature
-
Beyond tired: Understanding fatigue in Primary Biliary Cholangitis - Ipsen
-
New treatment for primary biliary cholangitis - Clínica FEHV
-
The Evolving Primary Biliary Cholangitis Landscape, with Craig Lammert, MD - HCPLive
-
Life with Primary Biliary Cholangitis: Sabrina’s Story - Ipsen
-
Primary Biliary Cholangitis: The Power of Patient Reported Outcomes - Ipsen
-
Primary Biliary Cholangitis and Chronic Arterial Hypertension in Pregnancy - Cureus
-
Double Trouble: Drug-Induced Autoimmune Hepatitis (AIH)-Primary Biliary Cholangitis (PBC) Overlap Syndrome Triggered by Hydralazine - Cureus
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.